Login / Signup

Cost-utility analysis and drug pricing for tirzepatide for type 2 diabetes in the Chinese market compared with semaglutide.

Shanshan HuChenyang ShiYuhang MaShuowen WangShengying GuChendong QiGuorong Fan
Published in: Diabetes, obesity & metabolism (2024)
This study shows that, using SEMA as a reference, the annual costs for TIRZ 10 and 15 mg are $1573.00-$1967.16 and $1576.54-$2133.96, respectively, for patients with type 2 diabetes in China.
Keyphrases
  • type diabetes
  • cardiovascular disease
  • health insurance
  • insulin resistance
  • metabolic syndrome
  • adipose tissue
  • skeletal muscle